NCT06806761

Brief Summary

This study aims to understand how balance and walking abilities recover after a stroke, using innovative tools like an interactive assessment game. By observing patients over time, the investigators seek to identify recovery patterns that can improve rehabilitation strategies tailored to individual needs. Interacting with a game designed to assess balance and movement, participants will perform tasks involving sitting balance, standing balance, and gait initiation. The game measures aspects like reaction time, movement accuracy, and postural control, providing detailed insights into recovery progress. These data will validate prediction models to support personalized care. The study is non-invasive, does not interfere with usual care, and prioritizes patient safety. The investigators' ultimate goal is to enhance the understanding of recovery, leading to better care and improved quality of life for stroke survivors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
32mo left

Started Jan 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Jan 2025Dec 2028

First Submitted

Initial submission to the registry

November 29, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

January 7, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

February 4, 2025

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2028

Last Updated

February 27, 2025

Status Verified

February 1, 2025

Enrollment Period

3.9 years

First QC Date

November 29, 2024

Last Update Submit

February 24, 2025

Conditions

Keywords

strokebalancelongitudinalgait initiation

Outcome Measures

Primary Outcomes (4)

  • Postural control

    Postural control during dynamic tasks (sitting, standing, gait initiation) measured using wearable sensors (e.g., IMUs) and other biomechanical measurement systems (e.g., force plates, Kinect cameras).

    Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Weight distribution

    Weight distribution during balance and movement tasks (standing, gait initiation) using force plates.

    Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Movement coordination

    Movement coordination assessed during functional motor tasks (sitting, standing, gait initiation) using wearable sensors (e.g., IMUs), force plates, and Kinect camera.

    Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Neuromuscular activity

    Neuromuscular activity evaluated during dynamic tasks (sitting, standing, gait initiation) using muscle activity measurement systems (e.g., EMG sensors).

    Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

Secondary Outcomes (17)

  • Reaction time

    Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Movement time

    Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Reaching or stepping accuracy

    Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Upper limb dynamics

    Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Error rate during dual-task performance

    Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • +12 more secondary outcomes

Study Arms (1)

Patients in the first 6 months after stroke

Participants in this study will be adults aged 18 years or older, following a supratentorial stroke, as defined by the World Health Organization (WHO). Inclusion will occur as soon as possible after hospital admission. Participants must be capable of providing informed consent, which may be written, verbal, or provided by proxy if necessary. Exclusion criteria include the presence of other neurological or orthopedic disorders (e.g., Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis) that impair motor function, severe complicating comorbidities imposing health risks (e.g., cardiovascular instability), significant deficits in communication, memory, or understanding (defined by a score of less than 21 on the Montreal Cognitive Assessment (MoCA)), and insufficient knowledge of Dutch, French, German, or English.

Other: Longitudinal prospective cohort study

Interventions

Description: Patients after stroke who meet the in- and exclusion criteria will be examined up to 6 times during the first 6 months after their stroke.

Patients in the first 6 months after stroke

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients in the first 6 months after stroke: Participants in this study will be adults aged 18 years or older, following a supratentorial stroke, as defined by the World Health Organization (WHO).

You may qualify if:

  • Adult (≥ 18 years)
  • Diagnosis of supratentorial stroke (as defined by the WHO)
  • Able to provide written or verbal informed consent (written, verbal or by proxy)

You may not qualify if:

  • Other neurological/orthopedic disorders (e.g., Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis) leading to impairments in motor function.
  • Severe complicating comorbidities imposing health risks (e.g., cardiovascular instability)
  • Severe deficits in communication, memory or understanding (Montreal Cognitive Assessment test (MoCA) \< 21); and
  • Insufficient knowledge of Dutch, French or English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inkendaal rehabilitation hospital

Sint-Pieters-Leeuw, Brussels Capital, 1602, Belgium

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Marc Degelaen

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
24 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 29, 2024

First Posted

February 4, 2025

Study Start

January 7, 2025

Primary Completion (Estimated)

December 9, 2028

Study Completion (Estimated)

December 9, 2028

Last Updated

February 27, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

This study is part of the EU Horizon 2020 TARGET project, following its DMP to ensure data is handled ethically, legally, and sustainably in line with FAIR principles (Findability, Accessibility, Interoperability, Reusability). The plan ensures systematic organization, quality consistency via standardized procedures, and compliance with GDPR, national laws, and EU requirements. Personal data is processed securely, only when necessary for project objectives, with approvals and written consent from participants. Methods include interviews, surveys, workshops, and questionnaires. Data is stored with robust backup and preservation strategies to prevent loss and ensure future usability. Sharing is (currently) restricted to the consortium under a signed data transfer agreement, with external sharing undecided. Data not publicly available includes: third-party data without permission for public release, data compromising IP protection, and participant data that cannot be fully anonymized.

Shared Documents
STUDY PROTOCOL, SAP, CSR

Locations